Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
However, starting with lower doses and advancing gradually remains the standard approach to identify any negative interactions unique to each person's post-surgical anatomy
This classification means it may occur in up to 1 in 10,000 patients
Other options include denosumab (an injection), and for very high-risk patients, bone-building "anabolic" medications like romosozumab or teriparatide
Adriaenssens AE, Biggs EK, Darwish T, Tadross J, Sukthankar T, Girish M, Polex-Wolf J, Lam BY, Zvetkova I, Pan W, et al
US$ 23.66
US$ 29.07
US$ 26.05
US$ 26.66
US$ 28.65
US$ 23.31
